Results of a systematic adverse drug reaction (ADR)-screening concerning bradycardia caused by drug interactions in departments of internal medicine in Rostock

International Journal of Clinical Pharmacology and Therapeutics

Volumn 40, Issue 3, 2002, Pages 116-119

  Haase, G ^a   Pietzsch, M ^a   Fahnrich A ^a   Voss, W ^a   Riethling, A K ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

ADR; Bradycardia; Interaction

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS GLYCOSIDE;

ADULT; AGED; ARTICLE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CHRONOTROPISM; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; FEMALE; GERMANY; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HUMAN; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL STAFF; OUTPATIENT CARE; PILOT STUDY; PROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING TEST;

EID: 0036195773     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP40116     Document Type: Article

References (3)

1. Unexpected or toxic drug reaction assessment (imputation)
2. Clinical significant new drug interactions
3. Adverse drug reactions monitoring-cost and benefit consideration. Part 2: Cost and preventability of ADR leading to hospital admission